January 16, 2025 - 16:10

The UK asset finance market experienced a notable decline of 4% in November 2024, according to recent data. While the commercial vehicle finance segment showed positive growth, other sectors, including new car and machinery finance, reported significant downturns.
The commercial vehicle sector demonstrated resilience, benefitting from increased demand as businesses seek to expand their fleets. This growth contrasts sharply with the new car finance market, which has faced challenges due to changing consumer preferences and economic uncertainties. The machinery finance sector also struggled, reflecting broader trends in manufacturing and investment.
Industry experts suggest that the decline in these sectors may be linked to rising interest rates and inflationary pressures, which have led to cautious spending among businesses and consumers alike. As the market navigates these challenges, stakeholders are hopeful that targeted strategies and innovations can stimulate growth in the asset finance landscape moving forward.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...